Bora Biologics and Protect Animal Health Form Antibody Collaboration

Bora Biologics and Protect Animal Health have entered a strategic, long-term, multi-project collaboration focused on advancing antibody-based animal health products, according to Newswire.

The collaboration includes development and manufacturing support for multiple monoclonal and bispecific antibody programs. Newswire said the programs are intended for U.S. and global animal health markets.

Focus on antibody-based animal health products

The announced work centers on monoclonal and bispecific antibodies, two antibody program types included in the collaboration. Bora Biologics and Protect Animal Health will work across development and manufacturing support under the multi-project arrangement, Newswire reported.

For veterinary and animal health sales professionals, the announcement places antibody-based products at the center of a new collaboration spanning product development and manufacturing activities. The stated market scope includes both the United States and global animal health markets.

Commercial relevance for animal health teams

Partnership announcements can be useful signals for teams following changes in animal health product portfolios, technical capabilities, and market focus. In this case, the companies’ stated emphasis is on multiple antibody programs rather than a single product.

Newswire characterized the relationship as strategic and long-term, with support planned across more than one project. Professionals tracking biologics in animal health may want to follow future updates from Bora Biologics and Protect Animal Health on the development and manufacturing work covered by the collaboration.

What was announced

• A strategic, long-term, multi-project collaboration between Bora Biologics and Protect Animal Health.
• Development and manufacturing support for multiple programs.
• A focus on monoclonal and bispecific antibody programs.
• Target markets in the United States and globally, according to Newswire.